Propafenone versus procainamide for conversion of atrial fibrillation to sinus rhythm

Clinical Cardiology

Volumn 21, Issue 10, 1998, Pages 763-766

  Mattioli, Anna Vittoria ^a   Lucchi, Giulia Ricci ^a   Vivoli, Daniela ^a   Mattioli, Giorgio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Atrial fibrillation; Cardioversion; Procainamide; Propafenone

Indexed keywords

PROCAINAMIDE; PROPAFENONE;

ADULT; AGED; ANTIARRHYTHMIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDUCED DISEASE; DRUG POTENCY; DRUG SAFETY; FEMALE; HEART ATRIUM FIBRILLATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; SINUS RHYTHM;

EID: 0031708020     PISSN: 01609289     EISSN: None     Source Type: Journal    
DOI: 10.1002/clc.4960211013     Document Type: Article

References (18)

1. Stroobandt R, Stiels B, Hoebrechts R, on behalf of the Propafenone Atrial Fibrillation Trial Investigators: Propafenone for conversion and prophylaxis of atrial fibrillation. Am J Cardiol 1997;79: 418-423
2. Anderson JL: Acute treatment of atrial fibrillation and flutter. Am J Cardiol 1996;78(8A):17-21
3. Fenster P, Comess KA, Marsh R, Katzenberg C, Hager WD: Conversion of atrial fibrillation to sinus rhythm by acute intravenous procainamide. Am Heart J 1983; 106:501-504
4. Chapman MJ, Moran JL, O'Fathartaigh ML, Peisach AR, Cunningham DN: Management of atrial tachyarrhythmias in the critically ill: A comparison of intravenous procainamide and amiodarone. Intens Care Med 1993; 19:48-52
5. Prystowsky EN, Benson DW, Fuster V, Hart GH, Kay GN, Myerburg RJ, Naccarelli GV, Wyse DG: Management of patients with atrial fibrillation. A statement for healthcare professionals from the subcommittee on electrocardiography and electrophysiology American Heart Association. Circulation 1996;93:1262-1277
6. Laupacis A, Albers G, Dunn M, Feinberg W: Antithrombotic therapy in atrial fibrillation. Chest 1992; 102(suppl 4):426S-433S
7. Manning WJ, Silverman DI, Keighley CS, Oettgen P, Douglas PS: Transesophageal echocardiography facilitated early cardioversion from atrial fibrillation using short-term anticoagulation: Final results of a prospective 4.5-year study. J Am Coll Cordial 1995; 25:1354-1361
8. Pritchett ELC: Management of atrial fibrillation. N Engl J Mal 1992;326:1264-127f
9. Kannel WB, Abott RD, Savage DD, McNamara PM: Epidemiolocic features of chronic atrial fibrillation: The Framingham Study. N EnglJMed 1982:3606:1018-1022
10. Bronner LL, Kanter DS, Manson JE: Primary prevention of stroke. NEnglMcd 1995;333:1392-I400
11. Madrid AH, Moro C, Marin-Huerta E, Mestre JL, Novo L, Costa A: Comparison of flecainide and procainamide in cardioversion of atrial fibrillation. EwHcartJ 1993;14:1127-1131
12. Boahene KA, Klein GJ, Yee R, Sharma AD, Fujimura O: Termination of acute atrial fibrillation in the Wolff-Parkinson-White syndrome by procainamide and propafenone: Importance of atrial fibrillatory cycle length. J Am Coll Cordial 1990; 16:1408-1414
13. Kondili A, Kastrati A, Balla I, NdrepcpaG. Pharmacological conversion of recent atrial fibrillation: A randomized study of seven antiarrhythmic drugs. Circulation 1995;92:I-193
14. Capucci A, Villani GQ, on behalf of the SATE Group. Propafenone oral loading dose plus digitalis in converting atrial fibrillation to sinus rhythm: A placebo-controlled multicenter study. Circulation 1995;92:I-775
15. Theodorakis GN, Markianos M, Kouroubetsis CK, Livanis EG, Paraskevaidis IA, Kremastinos DT: Clinical, adrenergic and heart endocrine measures in chronic atrial fibrillation as predictors of .conversion and maintenance of sinus rhythm after direct current cardioversion. Ear H cart J 1996; 17:550-556
16. Mattioli AV, Vivoli D, Bastia E: Dopplerechocardiographicparameters predictive of recurrence of atrial fibrillation of different etiological origins. J UltrasoundMcd 1997; 16:695-698
17. Cohen IS, Herschel J, Cohen S: Adverse reactions to quinidine in hospitalized patients: Findings based on data from Boston Collaborative Drug Surveillance Program. Prog CartliovascDis 1977;20: 151-163
18. Cowan JC: Antiarrhythmic drugs in the management of atrial fibrillation. Br HeartJ 1993;70:304-306